$95.00
CJC-1295 (No DAC) + Ipamorelin | Receptor Signaling Research Compound Blend
This blend combines CJC-1295 (No DAC), a modified GHRH (1-29) analog, with Ipamorelin, a selective pentapeptide growth hormone secretagogue, in a single lyophilized vial at an equal 5mg/5mg ratio. The combination provides a research formulation for examining two distinct receptor pathways associated with growth hormone signaling.
Mechanism & Research Rationale:
CJC-1295 No DAC is a GHRH (growth hormone-releasing hormone) analog studied for its interaction with the GHRH receptor pathway, while Ipamorelin is a selective GHRP studied for its activity at the ghrelin receptor (GHS-R1a). The combination provides a laboratory model for examining how GHRH and ghrelin receptor pathways interact through distinct receptors and intracellular signaling cascades.
Key Research Areas:
Product Specifications:
For laboratory and research use only. Not intended for human or animal consumption, administration, diagnostic, or therapeutic use. Not a drug, dietary supplement, or cosmetic. Not FDA-approved.
We take pride in treating every client, large or small, with the utmost regard.
No products in the cart.
Please confirm both statements before entering this website.
By entering, I acknowledge and agree to the Terms & Conditions and Privacy Policy.
Access remains blocked until both acknowledgments are selected.